Omeros (OMER) Return on Sales Growth (5y) (2015 - 2026)

Omeros (OMER) Return on Sales Growth (5y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,140.12 Bn 66,139.83 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.73 Bn -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn -
4 BeOne Medicines 472.60 Bn 467.81 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.34 Bn 115.09 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.14 Bn 61.39 Bn 3.31 Bn
7 Belite Bio 62.79 Bn 62.79 Bn -
8 Argenx Se 56.19 Bn 51.00 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn
10 Omeros 795.05 Mn 795.05 Mn 9.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Mar 31, 2025 1.00
Jun 30, 2022 9.00
Mar 31, 2022 7.00
Dec 31, 2021 -3.00
Sep 30, 2021 4.00
Jun 30, 2021 4.00
Mar 31, 2021 12.00
Dec 31, 2020 -6.00
Sep 30, 2020 13.00
Jun 30, 2020 27.00
Mar 31, 2020 354.00
Dec 31, 2019 117.00
Sep 30, 2019 279.00
Jun 30, 2019 2,043.00
Mar 31, 2019 546.00
Dec 31, 2018 82.00
Sep 30, 2018 161.00
Jun 30, 2018 83.00
Mar 31, 2018 -5.00